Knight Therapeutics Inc. (GUD.TO)
| Previous Close | 5.87 |
| Open | 5.87 |
| Bid | 5.90 x 0 |
| Ask | 5.92 x 0 |
| Day's Range | 5.87 - 5.95 |
| 52 Week Range | 4.35 - 5.95 |
| Volume | |
| Avg. Volume | 64,732 |
| Market Cap | 598.926M |
| Beta (5Y Monthly) | 0.49 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.16 |
| Earnings Date | May 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.75 |
GlobeNewswireKnight to Present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City
MONTREAL, May 07, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024 at 3:05 pm ET at the InterContinental New York Barclay hotel in New York City. About Knight Therapeutics Inc. Knight Therapeutics Inc.,
- GlobeNewswire
Notice of Knight Therapeutics' First Quarter 2024 Results Conference Call
MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its first quarter 2024 financial results on Thursday, May 9, 2024 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call. Date: Thursday, May 9, 2024 Time: 8:30 a.m. ET Telephone: Toll Free: 1-800-836-8184 o
Simply Wall St.Knight Therapeutics (TSE:GUD) shareholders have endured a 21% loss from investing in the stock five years ago
For many, the main point of investing is to generate higher returns than the overall market. But even the best stock...
